Lee‐Ling Lim
Impact in
- Nephrology top 0.1%
- Chronic Kidney Disease and Diabetes
-
- Cardiovascular Health and Risk Factors
- Blood Pressure and Hypertension Studies
Papers in
-
- Diabetes Treatment and Management 26
- Diabetes, Cardiovascular Risks, and Lipoproteins 19
- Diabetes Management and Research 18
- Diabetes Management and Education 11
- Nephrology 13
- Chronic Kidney Disease and Diabetes 12
- Co-authors
- Juliana Chan (17 shared papers)Huai Heng Loh (5 shared papers)Anne Hway Ann Yee (5 shared papers)A. Pik-Shan Kong (14 shared papers)Huai Seng Loh (4 shared papers)Jeyakantha Ratnasingam (21 shared papers)Elaine Chow (6 shared papers)Andrea O. Y. Luk (10 shared papers)
- Journals
- The Lancet (30 papers)Diabetes Research and Clinical Practice (5 papers)Journal of Diabetes Investigation (4 papers)Nature Medicine (3 papers)PLoS ONE (3 papers)
- Partner nations
- MalaysiaHong KongUnited States
In The Last Decade
Lee‐Ling Lim
137 papers receiving 78.4k citations
Lee‐Ling Lim's Hit Papers
Peers
Comparison fields: 5 of 227
- Nephrology 4.4k
- Cardiology and Cardiovascular Medicine 9k
- Health, Toxicology and Mutagenesis 5.2k
- Endocrinology, Diabetes and Metabolism 5.2k
- Health Information Management 2.4k
Countries citing papers authored by Lee‐Ling Lim
This map shows the geographic impact of Lee‐Ling Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee‐Ling Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee‐Ling Lim more than expected).
Fields of papers citing papers by Lee‐Ling Lim
This network shows the impact of papers produced by Lee‐Ling Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee‐Ling Lim. The network helps show where Lee‐Ling Lim may publish in the future.
Co-authors
The 25 scholars most cited alongside Lee‐Ling Lim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 152 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 Hit paper breakdown → | 2020 | 13876 |
| 2 | Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 Hit paper breakdown → | 2018 | 10887 |
| 3 | Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019 Hit paper breakdown → | 2020 | 8081 |
| 4 | Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 Hit paper breakdown → | 2020 | 7042 |
| 5 | Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017 Hit paper breakdown → | 2018 | 6792 |
| 6 | Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 Hit paper breakdown → | 2020 | 4976 |
| 7 | Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 Hit paper breakdown → | 2018 | 3958 |
| 8 | Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 3041 |
| 9 | Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2023 | 2997 |
| 10 | Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 Hit paper breakdown → | 2018 | 2573 |
| 11 | Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 1712 |
| 12 | Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 1679 |
| 13 | Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019 Hit paper breakdown → | 2020 | 1513 |
| 14 | The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 Hit paper breakdown → | 2020 | 1254 |
| 15 | Global Burden of Cardiovascular Diseases and Risks, 1990-2022 Hit paper breakdown → | 2023 | 948 |
| 16 | Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 Hit paper breakdown → | 2018 | 797 |
| 17 | Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 702 |
| 18 | Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 675 |
| 19 | Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 657 |
| 20 | Five insights from the Global Burden of Disease Study 2019 Hit paper breakdown → | 2020 | 525 |
About Lee‐Ling Lim
Lee‐Ling Lim is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology, Health Informatics, Demography and Cardiology and Cardiovascular Medicine, having authored 152 papers that have together received 80.7k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (26 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (19 papers), Diabetes Management and Research (18 papers), Chronic Kidney Disease and Diabetes (12 papers), Diabetes Management and Education (11 papers), Insurance, Mortality, Demography, Risk Management (10 papers), Cardiovascular Health and Risk Factors (8 papers) and Artificial Intelligence in Healthcare and Education (7 papers). The work is most often cited by research in Nephrology (4.4k citations), Cardiology and Cardiovascular Medicine (9k citations), Health, Toxicology and Mutagenesis (5.2k citations), Endocrinology, Diabetes and Metabolism (5.2k citations) and Health Information Management (2.4k citations). Lee‐Ling Lim has collaborated with scholars based in Malaysia, Hong Kong and United States. Frequent co-authors include Juliana Chan, Huai Heng Loh, Anne Hway Ann Yee, A. Pik-Shan Kong, Huai Seng Loh, Jeyakantha Ratnasingam, Elaine Chow, Andrea O. Y. Luk, Siew Pheng Chan and Alexander Tong Boon Tan. Their work appears in journals such as The Lancet, Diabetes Research and Clinical Practice, Journal of Diabetes Investigation, Nature Medicine and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.